HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Intimal arteritis in renal allografts: new takes on an old lesion.

AbstractPURPOSE OF REVIEW:
Inflammation of the arterial wall has been recognized as a key element of rejection since the early studies of pathologic changes in transplanted organs. Better elucidation of the mechanisms involved in endothelial injury has brought increasing complexity to the diagnostic classification of this lesion in the context of transplantation, and has affected the clinical management of patients with allograft rejection. Here, we examine how our understanding of the significance of intimal arteritis in renal graft biopsies has evolved in the past decades.
RECENT FINDINGS:
Recognition that antidonor antibody may cause intimal arteritis has prompted revision of histologic classifications of transplant rejection. Although molecular signatures/biomarkers are being developed and proposed as new tools for aiding in the identification of cell-mediated and antibody-mediated types of rejection, histological examination is still needed to identify intimal arteritis in allograft biopsies. Outcome studies are contributing to clarify the prognostic significance of intimal arteritis in transplant rejection.
SUMMARY:
Intimal arteritis remains an important histologic feature of allograft rejection, which comes in different nuances requiring tailored therapeutic approaches.
AuthorsSerena M Bagnasco, Edward S Kraus
JournalCurrent opinion in organ transplantation (Curr Opin Organ Transplant) Vol. 20 Issue 3 Pg. 343-7 (Jun 2015) ISSN: 1531-7013 [Electronic] United States
PMID25944226 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Review)
Topics
  • Arteritis
  • Graft Rejection (immunology)
  • Humans
  • Kidney (blood supply, pathology)
  • Kidney Transplantation (adverse effects)
  • Prognosis
  • Transplantation, Homologous

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: